Technical Analysis for MYOV - Myovant Sciences Ltd.

Grade Last Price % Change Price Change
D 21.89 4.24% 0.89
MYOV closed up 4.24 percent on Friday, March 5, 2021, on 83 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical MYOV trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Multiple of Ten Bullish Other 0.00%
BB Squeeze Ended Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
MACD Bearish Centerline Cross Bearish 4.24%
MACD Bearish Signal Line Cross Bearish 4.24%
Expansion Pivot Sell Setup Bearish Swing Setup 4.24%
Bollinger Band Squeeze Range Contraction 4.24%
BB Squeeze + Lower Band Touch Range Contraction 4.24%
Older End-of-Day Signals for MYOV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% 2 days ago
60 Minute Opening Range Breakout 2 days ago
Up 2% 2 days ago
Up 1% 2 days ago
Lower Bollinger Band Support 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist, for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company also intends to develop RVT-602, an oligopeptide kisspeptin analog, for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. was founded in 2016 and is based in Hamilton, Bermuda. Myovant Sciences Ltd. operates as a subsidiary of Roivant Sciences Ltd.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pain Prostate Cancer Endocrine System Hormones Amines Fertility Reproduction Infertility Related Disorders Endometriosis Fibroids Advanced Prostate Cancer Gnrh Antagonists Male Infertility Pyrimidines Roivant Sciences Uterine Fibroid Uterine Fibroids Gonadotropin Releasing Hormone Antagonist

Is MYOV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 30.9
52 Week Low 5.98
Average Volume 1,158,265
200-Day Moving Average 19.46
50-Day Moving Average 23.11
20-Day Moving Average 22.73
10-Day Moving Average 22.56
Average True Range 1.53
ADX 13.92
+DI 17.85
-DI 31.83
Chandelier Exit (Long, 3 ATRs ) 20.08
Chandelier Exit (Short, 3 ATRs ) 24.09
Upper Bollinger Band 24.68
Lower Bollinger Band 20.78
Percent B (%b) 0.28
BandWidth 17.13
MACD Line -0.17
MACD Signal Line -0.09
MACD Histogram -0.0782
Fundamentals Value
Market Cap 1.98 Billion
Num Shares 90.6 Million
EPS -3.98
Price-to-Earnings (P/E) Ratio -5.50
Price-to-Sales 64.89
Price-to-Book 70.01
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.58
Resistance 3 (R3) 25.19 23.58 24.96
Resistance 2 (R2) 23.58 22.64 23.77 24.76
Resistance 1 (R1) 22.73 22.06 23.15 23.12 24.55
Pivot Point 21.12 21.12 21.33 21.31 21.12
Support 1 (S1) 20.27 20.18 20.70 20.66 19.23
Support 2 (S2) 18.66 19.60 18.85 19.02
Support 3 (S3) 17.81 18.66 18.82
Support 4 (S4) 18.20